Jan 10, 2023 / 03:30PM GMT
Rachel Marie Vatnsdal Olson - JPMorgan Chase & Co, Research Division - Analyst
Good morning, everyone. This is Rachel Vatnsdal from the life science tools and diagnostics team from JPMorgan. I'm joined today by Marc Casper, CEO of Thermo Fisher. So today will be a 40-minute presentation. We'll start off with 20-minute presentation from Marc. And then after that, we'll shift into Q&A. Just like all the other sessions that you've been to this week, we'll have mic runners throughout the room. So if you do have a question, please raise your hand but wait until you have a mic in your hand to ask your question. Otherwise, for those of you joining us online, feel free to answer a question via the webcast.
With that, Marc, I will let you take it away.
Marc N. Casper - Thermo Fisher Scientific Inc. - Chairman, President & CEO
Good morning, everyone. It is great to be back in San Francisco. Rachel, thank you for having us. I thought about this conference, it's just great to see so many people. And yesterday, it was a great day with customers and so
Thermo Fisher Scientific Inc at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot